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The Myc oncoprotein family comprises transcription
factors that control multiple cellular functions and
are widely involved in oncogenesis. Here we report
the identification of Myc-nick, a cytoplasmic form of
Myc generated by calpain-dependent proteolysis at
lysine 298 of full-length Myc. Myc-nick retains
conserved Myc box regions but lacks nuclear locali-
zation signals and the bHLHZ domain essential for
heterodimerization with Max and DNA binding. Myc-
nick induces a-tubulin acetylation and altered cell
morphology by recruiting histone acetyltransferase
GCN5 tomicrotubules. Duringmuscle differentiation,
while the levels of full-length Myc diminish, Myc-
nick and acetylated a-tubulin levels are increased.
Ectopic expression of Myc-nick accelerates myo-
blast fusion, triggers the expression of myogenic
markers, and permits Myc-deficient fibroblasts to
transdifferentiate in response to MyoD. We propose
that the cleavage of Myc by calpain abrogates the
transcriptional inhibition of differentiation by full-
length Myc and generates Myc-nick, a driver of cyto-
plasmic reorganization and differentiation.INTRODUCTION
The Myc family (c-Myc, N-Myc, and L-Myc) of basic-helix-loop-
helix-zipper (bHLHZ) transcription factors controls the expres-
sion of a large number of target genes and noncoding RNA
loci. These Myc targets mediate the physiological effects of
Myc on cell proliferation, metabolism, apoptosis, growth, and
differentiation (Eilers and Eisenman, 2008). To promote tran-
scriptional activation at target genes, Myc forms heterodimers
with its partner Max and recruits chromatin-modifying com-
plexes to E-box-containing promoters. Myc is also involved in
transcriptional repression through the inhibition of the transcrip-
tional activator Miz1 (Kleine-Kohlbrecher et al., 2006). Aberrant
elevation of Myc levels has been shown to contribute to the
genesis of many types of human tumors (Hanahan and Wein-
berg, 2000).480 Cell 142, 480–493, August 6, 2010 ª2010 Elsevier Inc.Myc family proteins contain highly conserved regions termed
Myc boxes (MB) that are essential for Myc’s biological activities
(see Figure 1E). A major determinant of Myc transcriptional
function is MBII, which is the site of recruitment of coactivator
complexes containing histone acetyltransferases (HATs) such
as GCN5 (McMahon et al., 2000) and TIP60 (Frank et al.,
2003). MBI functions as a phosphorylation-dependent binding
site for the ubiquitin ligase Fbw7 (Welcker et al., 2004), whereas
MBII is one of the binding sites for the ligase SKP2 (Kim et al.,
2003; von der Lehr et al., 2003). Fbw7 and Skp2 both contribute
to the rapid degradation of Myc protein (t1/2 20 min). The C
terminus of Myc harbors nuclear localization signals and the
bHLHZ motif that mediates dimerization with Max and DNA
binding.
Several variant forms of Myc protein have been previously
identified. All of them are nuclear-localized, low-abundance
proteins generated by alternative translation initiation. A weak
CUG translational initiation site, upstream and in-frame of the
predominant AUG codon, produces an N-terminally extended
form of c-Myc called c-Myc1 (Hann et al., 1988). Another Myc
protein variant is MycS, generated by internal translational initia-
tions at two AUG codons located 100 amino acids from the
normal N terminus (Spotts et al., 1997). MycS lacks MBI but
contains MBII and retains much of full-length Myc’s biological
activity (Xiao et al., 1998).
As expected, given their broad role as transcriptional regula-
tors, Myc family proteins are predominantly localized to the
cell nucleus during proliferation. Surprisingly, however, there
have been multiple reports of cytoplasmically localized Myc,
mostly in differentiated cells. For example, N-Myc localiza-
tion was shown to change from nuclear to cytoplasmic in
differentiating neurons of the neural crest, retinal ganglion
cells, neurons of spinal ganglia (Wakamatsu et al., 1993, 1997),
and Purkinje cells (Okano et al., 1999; Wakamatsu et al.,
1993). Cytoplasmic Myc was also reported in tumors with
diverse origins (Bai et al., 1994; Calcagno et al., 2009; Pietilai-
nen et al., 1995). These studies relied on immunostaining pro-
tocols and the form of the Myc protein involved was not char-
acterized.
Interestingly, association of Myc with several cytoplasmic
proteins has been reported. The best characterized is the
interaction of c-Myc with tubulins (Alexandrova et al., 1995)
(Koch et al., 2007; Niklinski et al., 2000). Myc has also been
reported to interact with other proteins that are predominantly
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Figure 1. Identification of Myc-Nick in the Cytoplasm of Cells Grown at High Density
(A) Total cell lysates of Rat1myc null fibroblasts infected with c-Myc or empty retroviral vectors were prepared for western blot by adding boiling sample buffer.
(B and C) Nuclear and cytoplasmic fractions of HFF cells expressing c-Myc were prepared 48 hr after plating at the indicated increasing densities.
(D) Immunoprecipitation of HA-c-Myc (N-terminal tag) with anti-N262, anti-HA, and normal IgG from nuclear and cytoplasmic fractions of HFFs. Note that Max is
only coimmunoprecipitated along with nuclear c-Myc.
(E) Schematic representation of antibody mapping.
(F) HFF cells infected with c-myc-expressing retrovirus were cultured for 4 days after reaching confluency (middle and right panels) and compared with a
subconfluent culture (left panel) by immunofluorescence using N262 and 9E10 antibodies.
See also Figure S1.cytoplasmic, such as cdr2 (Okano et al., 1999) and AMY-1 (Taira
et al., 1998). However the nature of the cytoplasmic Myc protein
and its potential function remains an enigma. Here we report the
identification of Myc-nick, a cytoplasmically localized cleavage
product of Myc, and provide evidence for its role in cytoskeletal
organization and cell differentiation.RESULTS
Myc-Nick Is a Truncated Form of Myc Localized
Predominantly in the Cytoplasm
While studying regulation of c-Myc degradation, we noticed an
inverse correlation between the levels of full-length c-Myc andCell 142, 480–493, August 6, 2010 ª2010 Elsevier Inc. 481
a cytoplasmic 42 kDa protein in anti-Myc immunoblots derived
from confluent fibroblast cultures (Figures 1A and 1B). As
described below, this protein, which we have named Myc-nick,
is a cytoplasmic cleavage product of full-length c-Myc gener-
ated at high cell density (Figure 1B). Myc-nick is recognized by
three antibodies against the N-terminal two-thirds of c-Myc
(anti-Myc N262, 274, 143; Figures 1A and 1B and Figure S1A
available online) but not by anti- C-terminal antibodies (anti-
Myc 9E10, C19; Figure 1C). Furthermore, an anti-HA antibody
immunoprecipitates Myc-nick from cytoplasmic extracts of cells
expressing N-terminally HA-tagged c-Myc (Figure 1D). In addi-
tion, cytoplasmic Myc bearing N-terminal but not C-terminal
epitopes is detected by imunofluorescence in confluent cultures
(see below, Figure 1F). Together, these results indicate that
Myc-nick is a truncated protein lacking the C-terminal portion
of c-Myc while preserving an intact N terminus comprising
Myc boxes I–III (Figure 1E). This makes Myc-nick distinct from
any other previously identified form of Myc (see Introduction).
We have detected endogenously expressed Myc-nick in the
cytoplasm of a large number of cell lines including human
foreskin fibroblasts (HFFs), Wi38, L cells, HCT116, SW480, HeLa
(Figure S1B), C2C12 (Figure 7D), 293T, A431, Rat1, U2OS, ES
cells, andmouse neurospheres (not shown), in addition tomouse
tissues such as muscle, brain, and cerebellum (Figure 7A and
Figure S7A). We also observed Myc cytoplasmic localization
by immunofluorescence of confluent cultures of HFFs (Figure 1F
and Figure S5A) and Rat1 myc null cells (not shown) expressing
c-myc. Therefore a protein with the size and properties of Myc-
nick is very widely expressed. In some settings we observe
relatively low and variable amounts of Myc-nick in the nucleus
(e.g., Figure 2A).
Myc-Nick Is Generated by Proteolytic Cleavage
of c-Myc in the Cytoplasm
We considered the possibility that Myc-nick is generated in the
cytoplasm because the nuclear export inhibitor Leptomycin B
had no effect on the production or cytoplasmic localization of
Myc-nick (Figure 2A). To determine whether a cytoplasmic
activity could convert full-length c-Myc into Myc-nick, we incu-
bated in vitro-translated [35S]-methionine-labeled c-Myc or puri-
fied full-length recombinant c-Myc with nuclear or cytoplasmic
extracts from Rat1 myc null cells. Only cytoplasmic extracts
(CE) were capable of producing a protein (Figures 2B–2D) having
the same apparent molecular weight as Myc-nick that was
recognized by antibodies against the N terminus but not C
terminus of c-Myc (Figure S2A). Increasing the incubation time
with CE augmented Myc-nick production and decreased the
amounts of full-length c-Myc input (Figure 2C). In agreement
with our observations made in vivo, CE of dense cultures were
more efficient in cleaving c-Myc than CE of sparse cultures
(Figure S2B). In experiments designed to characterize the cyto-
plasmic activity responsible for formation of Myc-nick, we found
that inhibitors of transcription or translation had no effect on
Myc-nick formation (Figure 2E) whereas heating or adding
protease inhibitors to the CE blocked Myc-nick, consistent
with proteolysis (Figure 2F). Whereas MG132, an inhibitor of the
proteasome (and other cysteine proteases), blocked Myc nick
formation, specific proteasome inhibitors such as Epoxomycin482 Cell 142, 480–493, August 6, 2010 ª2010 Elsevier Inc.and Lactacystein failed to block the formation of Myc-nick
in vitro and in vivo (Figures 2G and 2H). In addition, inhibition
of either the Fbw7 or Skp2 degradation pathways, known to be
responsible for proteasomal Myc turnover, had no effect on
Myc-nick formation (data not shown). Moreover, incubation of
Myc with 20S and 26S proteasomes failed to produce Myc-
nick (not shown). These results indicate that full-length c-Myc
is converted into Myc-nick by a cytoplasmic protease that is
independent of the proteasome.
Myc Is Cleaved by a Calcium-Activated Calpain
to Produce Myc-Nick
In a systematic search for the proteases mediating cytoplasmic
cleavage of Myc, we ruled out both caspases and lysosomal
proteases on the basis of inhibitors and cleavage conditions
(Figure S2C). However, we found that all calpain inhibitors tested
including calpeptin, calpain inhibitor XII (Figure 3A), and calpain
inhibitor VI (Figure 3B) blocked the formation of Myc-nick in vitro
and in vivo. Moreover, MG132, although well known as a protea-
some inhibitor, has also been shown to inhibit calpains (Mailhes
et al., 2002). Calpains had been linked toMyc stability earlier, but
the antibodies used in those studies would not have detected
Myc-nick (Gonen et al., 1997; Small et al., 2002). Calpains
comprise a large family of calcium-dependent cytoplasmic
cysteine proteases that function at neutral pH and are primarily
associated with partial protein cleavage rather than complete
protein degradation. The most well studied members of this
family are mcalpain and mcalpain. These ubiquitously expressed
catalytic subunits form functional heterodimers with a calpain
regulatory subunit (calpain r) to bind calcium. To determine
whether Myc-cleavage is regulated by calcium-activated cal-
pains, we employed siRNA to knock down calpain r in cells
expressing c-Myc either endogenously or under control of
a retroviral vector. In both settings a partial silencing of calpain
r correlated with decreased Myc-nick and increased full-length
c-Myc (Figure 3C). Knockdown of m or mcalpains alone did not
block the formation of Myc-nick, most likely due to the presence
of other redundant calpains (not shown). Because calpain
activity is calcium dependent we next examined the effects on
Myc-nick of modulating calcium levels. Treatment with the
calcium chelators Bapta or EGTA reduced the ability of CE to
cleave c-Myc (Figures 3D and 3E). Incubation of either IVT
c-Myc (Figure 3F) or recombinant c-Myc (Figure 3G) with purified
m or mcalpain (together with calpain r) produced Myc-nick.
These results demonstrate that Myc-nick is directly generated
by calcium-dependant calpain cleavage of full-length c-Myc.
Lysine 298 Is thePrimaryCalpainCleavage Site in c-Myc
To map the calpain cleavage region on c-Myc, we used a series
of internal deletion mutants lacking 60 residue segments (c-Myc
DA-DG) (Tworkowski et al., 2002) (Figure 3H) and determined
whether any failed to generate a shorter c-Myc protein. Only
the deletion of residues 252–315 (DE) resulted in loss of a Myc-
nick-like product (Figure 3I). This region contains a high scoring
PEST domain, often present in unstable proteins and frequently
associated with calpain cleavage sites. We further narrowed our
search to residues 270–315, based on the ability of antibody 274
to detect Myc-nick (Figure S1A and Figure 3H). Although there is
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Figure 2. Myc-Nick Is a Product of c-Myc Cytoplasmic Cleavage Independent of the Proteasome
(A) CRM1-dependant nuclear export is not involved in the formation or localization of Myc-nick. Rat1 myc null cells infected with c-Myc were treated with
leptomycin B (LB) for 4 hr before harvesting.
(B) c-Myc gives rise to Myc-nick in vitro when incubated with cytoplasmic extracts. Radiolabeled IVT c-Myc was incubated for 2 hr with cytoplasmic (CE) or
nuclear extracts (NE) from Rat1 c-myc null cells.
(C) Timecourse of in vitro cleavage of c-Myc.
(D) Recombinant c-Myc is cleaved in the presence of CE. One microgram of recombinant c-Myc was incubated with 30 mg of CE and processed for western blot.
(E) IVT c-Myc was incubated with CE for 4 hr in the presence of of Actinomycin D (ActD) or cyclohexamide (CHX).
(F) The cleavage of c-Myc is inhibited by protease inhibitors and by heat inactivation. CE was boiled prior to incubation with IVT c-Myc and the protease inhibitor
(PI) was added to the incubation mixture.
(G and H) The cleavage of c-Myc is inhibited by MG132, but not by Lactacystein or Epoxomycin. (G) IVT c-Myc was incubated with CE, in the presence of
increasing amounts of MG132, Lactacystein, and Epoxomycin for 1 hr. (H) Rat1 myc null cells expressing c-Myc were incubated with MG132, Lactacystein,
or Epoxomycin for 2 hr prior to harvesting. Nuclear (N) and cytoplasmic (C) fractions are shown.
See also Figure S2.no universal consensus for a calpain cleavage site, a comparison
of 106 sites present in 49 known calpain substrates indicated
a preference for calpain cleavage after K or R, and to lesser
extent Y, especially when these amino acids are flanked by P,
V, and L (Figure 3J) (Tompa et al., 2004). We noted a region local-
ized C-terminal to the PEST domain containing the sequence
PLVLKRC (Figure 3H, marked in red). This region is evolutionarily
conserved in c-Myc and N-Myc but not L-Myc (Figure S3A),
consistent with the fact that c-Myc and N-Myc, but not L-Myc,are cleaved (Figures S3B and S3C). To determine whether this
region functions as a calpain cleavage site, we synthesized
a 10 amino acid peptide corresponding to the putative c-Myc
calpain cleavage region (291–300) and to another nearby region
of c-Myc (236–245) (Figure 3H, in red and blue, respectively) and
asked whether they could act as competitive inhibitors of Myc-
nick formation in vitro. Addition of increasing amounts of the
peptide containing the putative calpain cleavage site blocked
the formation of Myc-nick in vitro whereas the control peptideCell 142, 480–493, August 6, 2010 ª2010 Elsevier Inc. 483
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Figure 3. Myc-Nick Is Generated by Calpain
Cleavage of Full-Length Myc
(A) IVT c-Myc was incubated with CE for 1 hr in the
presence of the calpain inhibitors calpeptin and
calpain inhibitor XII.
(B) Dense cultures of HFF cells infected with a
c-Myc retroviral vector were incubated with cal-
pain inhibitor VI for 2 hr prior to harvesting.
(C) siRNA for calpain regulatory subunit (Reg)
reduces the formation of Myc-nick in HCT116
and HFF-Myc cells.
(D) Rat1myc null cells were incubated for 2 hr in the
presence of the calcium chelant Bapta, and then
cytoplasmic extracts were prepared and incubated
with IVT c-Myc (as in 2B).
(E) IVT c-Myc was incubated with CE for 1 hr in the
presence of increasing amounts of EGTA.
(F) IVT c-Myc was incubated with purified recombi-
nant mcalpain or mcalpain and r subunit for 1 hr
on ice.
(G) One hundred nanograms of purified mcalpain
and r subunit was incubated with 2 mg of recombi-
nant c-Myc for 30 min on ice.
(H) Schematic representation of c-Myc protein
indicating A-G deletion regions (deletion end-
points indicated above), putative calpain cleavage
region in red.
(I) c-Myc and the deletion mutants DA-DG were
expressed in 293T cells, and 48 hr later the pres-
ence of a Myc-nick-like protein in cytoplasmic
extracts was determined.
(J) Amino acid preference for calpain cleavage
region according to Tompa et al. (2004). P1–P3
indicate the position of preferred residues in rela-
tion to the cleavage site, bold letters indicate the
c-Myc calpain cleavage site.
(K) IVT c-Myc was incubated with CE in the pres-
ence of a peptide that contains the potential
calpain cleavage site (amino acids 291–300 in
red) or a nearby sequence (amino acids 236–245
in blue).
(L) WT and D291–300 IVT c-Myc were incubated
with CE for 1 hr (as in 2B).
(M) IVTWT, L295A, K298A, and K299A c-Myc were
incubated with CE for the indicated time points.
(N) Cleavage products produced from the indi-
cated c-Myc mutants in 293T cells.
See also Figure S3.had no effect (Figure 3K). Next, we generated a deletion mutant
of Myc lacking residues 291–300 and found it to be resistant to
cleavage by CE (Figure 3L). When this mutant was ectopically
expressed in 293T cells the cleavage was also reduced in
comparison to the wild-type (WT) c-Myc (Figure 3N), indicating
that this is the major calpain cleavage site within c-Myc. Next,
we made point mutations in the calpain cleavage region (labeled
with asterisks in Figure 3H) and assessed their cleavage. We
found that the K298A mutation reduced the cleavage of c-Myc
in vitro (Figure 3M) and in vivo when ectopically expressed in
293T cells (Figure 3N). Although K298 appears to be the major
calpain cleavage site, a K298A mutant was still cleaved in vivo
most likely because when this residue is mutated the cleavage
is shifted to R299 (and perhaps L297, V296). We also identified
weaker calpain cleavage sites localized in the C terminus of484 Cell 142, 480–493, August 6, 2010 ª2010 Elsevier Inc.Myc that become more pronounced in the cleavage-deficient
mutants.
Expression of Myc-Nick Alters Cell Morphology
and Increases Acetylation of a-Tubulin
To study Myc-nick function, we generated a truncated form of
Myc containing amino acids 1–298 (referred to as Myc-nick*).
We found that ectopically expressed Myc-nick* is localized
predominantly to the cytoplasm and migrates on SDS-PAGE
with the same apparent molecular weight asMyc-nick generated
by cleavage of full-length c-Myc (Figure 4A). Myc-nick is
degraded at a comparable rate to full-length c-Myc with a half-
life of about 30 min (data not shown). Because Myc-nick
contains the MBI phosphodegron, with its GSK3b phosphoryla-
tion and Fbw7-binding sites, we would expect Myc-nick to be
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Figure 4. The Expression of Myc-Nick* Promotes Changes in Cell Morphology
(A) Myc-nick* (1–298) is cytoplasmic and has the same apparent molecular weight as Myc-nick derived from full-length c-Myc (compare lanes 2 and 4, upper
panel). Rat1 myc null cells expressing empty vector, full-length c-Myc, and Myc-nick were fractionated into nuclear (N) and cytoplasmic (C) fractionations.
(B) Myc-nick*-expressing cells extend protrusions at the wound edge. A confluent monolayer of Rat1 myc null cells expressing either vector or Myc-nick was
scratched using a 100 ml tip and phase contrast images were taken at 12 hr.
(C) Rat1 myc null cells expressing empty vector, c-Myc, and Myc-nick at 14 days after selection.
See also Figure S4.degraded through similar proteasomal pathways as full-length
Myc. Indeed, blocking proteasome activity by pharmacological
inhibitors or by silencing E3 ligases and components of the pro-
teasome induced the stabilization of both full-length Myc and
Myc-nick (data not shown). Calpain inhibitors are incapable of
inducing accumulation of Myc-nick, indicating that calpains are
unlikely to play a major role in Myc-nick turnover in vivo.
Whereas overexpression of full-length c-Myc in Rat1a myc
null fibroblasts is associated with increased proliferation
and apoptosis, the ectopic expression of Myc-nick* had no
detectable effect on either cell doubling time or survival (data
not shown). However, Myc-nick*-expressing cells displayed
dramatic morphological changes—they appeared spindle-like
with long protrusions that occasionally formed intercellular con-
tacts (Figure 4C, Figure S4, Figure S5C). This morphology was
specific for Myc-nick* expression and could not be produced
by expressing the C-terminal 100 residues of c-Myc (not shown).
Introducing a scratch wound across a confluent cell monolayer
showed that whereas control cells migrated into the wound by
extending lamellipodia, Myc-nick*-expressing cells aligned
parallel to each other and extended long protrusions into the
wound (Figure 4B).
The morphological changes induced by Myc-nick* are
suggestive of altered cell-cell contacts and/or major cytoskeletal
reorganization. The elongated cellular protrusions present in
Myc-nick-expressing cells resemble specialized structures
formed by stable microtubules. Because stable microtubules
display increased acetylation of a-tubulin on lysine 40 (Hubbert
et al., 2002), we stained Myc-nick*-expressing cells with anti-bodies against a-tubulin and acetylated a-tubulin. Figure 5A
shows that although acetylated a-tubulin immunostaining
in vector and c-Myc-expressing cells is low, Myc-nick* cells
display intense staining of elongated structures (Figures 5A
and 5F). This was confirmed by immunoblotting for acetylated
a-tubulin in Rat1 myc null or 293T cells expressing Myc-nick*
(Figure 5C, Figure S6B). Importantly neither the levels of total
cellular acetylated lysine (Figure S6A) nor the levels of tyrosi-
nated tubulin (not shown) were affected. To ask whether Myc-
nick* expression increasedmicrotubule stability, we treated cells
expressing Myc-nick*, c-Myc, or vector with nocodozole for
15 min. This treatment disrupted unstable microtubules with
a half-life of about 10 min but not stable microtubules with
a half-life >2 hr. Only Myc-nick*-expressing cells possessed
microtubules that survived nocodozole treatment and these
stained strongly with antiacetylated a-tubulin (Figure 5B).
Myc-Nick Interacts with a- and b-Tubulins
We observed partial cytoplasmic colocalization between Myc
and a-tubulin in several cell types expressing c-Myc or Myc-
nick (Figure 5E; Figures S5A–S5C). Using 293T cells expressing
GFP-tubulin and Myc-nick we performed immunoprecipitation
with anti-GFP and immunobloted with anti-Myc. Myc-nick was
coimmunoprecipitated with GFP-tubulin but not GFP-EB1,
a microtubule-binding protein (Figure S5D). In addition, immuno-
precipitation of either c-Myc or endogenous a-tubulin from cyto-
plasmic extracts indicated that Myc-nick interacts with a-tubulin
in vivo (Figure 5D). To examine in vitro interactions we incubated
35[S]-methionine-labeled IVT c-Myc with purified brain tubulinsCell 142, 480–493, August 6, 2010 ª2010 Elsevier Inc. 485
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Figure 5. Myc-Nick* Cells Display In-
creased Levels of Acetylated a-Tubulin
and Microtubule Stabilization
(A) Immunofluorescence for a-tubulin (upper
panels) and acetylated a-tubulin (lower panels) of
Rat1 myc null cells infected with empty vector,
c-Myc, or Myc-nick*.
(B) As for (A) but incubated in the presence of
nocodazole for 15 min prior to fixation.
(C) Immunoblotting of Rat1 cell extracts using anti-
bodies against the indicated proteins.
(D) NE or CE of Rat1 myc null cells express-
ing c-Myc were immunoprecipitated with anti
a-tubulin or normal mouse IgG and immunoblotted
for Myc (top panel), or immunoprecipitated with
anti-c-Myc N262 antibody, and immunoblotted
with anti-a-tubulin.
(E) Immunofluorescence for Myc and acetylated
a-tubulin in A431 lung epithelial cells cell trans-
fected with Myc-nick.
(F) Detail of Myc-nick-expressing cell stained for
acetylated a-tubulin.
See also Figure S5.for 1 hr, then immunoprecipitated a, b, g, bIII and acetylated
a-tubulin and exposed the gel to detect radioactive Myc. Full-
length c-Myc was coimmunoprecipitated mostly with b-tubulin
(Figure S5E, middle panel). We also incubated IVT c-Myc with
CE for 1 hr to produce Myc-nick and then performed immuno-
precipitation for tubulins as above. The results showed that
Myc-nick interacts with a- and b-tubulin (Figure S5E, upper
panel). The binding of Myc-nick to tubulin is consistent with the
previous report of an N-terminal region of Myc capable of asso-
ciating with tubulin (Alexandrova et al., 1995).
Myc-Nick Directly Regulates a-Tubulin Acetylation
through GCN5
Because Myc-nick lacks the Myc C-terminal dimerization and
DNA-binding domains, we surmised that the increase in acety-
lated a-tubulin induced by Myc-nick* expression is independent
of Myc transcriptional activity. One possibility is that Myc-nick486 Cell 142, 480–493, August 6, 2010 ª2010 Elsevier Inc.recruits an acetyltransferase to microtu-
bules. We observed marked acetylation
of a-tubulin in cytoplasmic extracts incu-
bated in the presence of either recombi-
nant c-Myc (Figure 6A) or IVT c-Myc
(Figure 6B and Figure S6C). Importantly,
Myc proteins are known to associate
with the acetyltransferases GCN5 and
TIP60 (Frank et al., 2003; Sterner and
Berger, 2000) via TRRAP that interacts
with MBII (residues 106–143) (McMahon
et al., 1998). We therefore tested a Myc-
nick deletion mutant lacking Myc box II
(DMBII) and found that its ability to pro-
mote a-tubulin acetylation was reduced
(Figures 6C and 6D). In addition, the
DMBII Myc-nick* mutant failed to induce
the cell morphological changes that wehad detected with WT Myc-nick* whereas a comparably sized
deletion in a region adjacent toMBIIwas similar toWT (Figure 6E).
The dependence on MBII for tubulin acetylation and altered
cell morphology suggests involvement of the acetyltranferases
known to bind this region. We detected substantial amounts of
GCN5 and TRRAP in the cytoplasm (Figure S6D), whereas
Tip60 was predominantly nuclear (not shown). To test GCN50s
involvement in a-tubulin acetylation we performed siRNA-medi-
ated knockdown of TRRAP and GCN5 in Myc-nick*-expressing
cells and found that decreasing either one of these proteins
reduced the levels of acetylated a-tubulin (Figure 6F) and
reverted the changes in cell morphology induced by Myc-nick
to that of vector-infected cells (Figure 6G). Moreover, GCN5
coimmunoprecipated with a-tubulin and Myc in cytoplasmic
extracts of 293T cells transfected with GCN5 (Figure 6H).
Both ectopic expression of GCN5 in 293T cells (Figures 6D
and 6I) and addition of full-length recombinant GCN5 to
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Figure 6. c-Myc and the HAT GCN5 Promote a-Tubulin Acetylation
(A) CE was incubated with recombinant c-Myc and c-Myc dilution buffer or (B) with c-Myc IVT or vector IVT for 1 hr at 37C. The samples were immunoblotted as
indicated.
(C) CE was incubated with IVT vector, c-Myc, Myc-nick, and Myc-nick DMBII (D106–143) for 30 min at 37C, then processed for immunoblotting.
(D) 293T cells were transfected with empty vector, GCN5, Myc-nick, and Myc-nick DMBII and processed for immunoblotting after 48 hr.
(E) Rat1 myc null cells were infected as indicated and photographed 10 days after selection.
(F and G) Rat1myc null cells expressingMyc-nick were transfected with 100 nM of control, TRRAP, or GCN5 siRNA and 76 hr later processed for immunoblotting
(F) or photographed (G).
(H) CE of 293T cells transfected with empty or GCN5 vectors were immunoprecipitated with anti-a-tubulin or anti-Myc (143+274) and immunoblotted for GCN5.
(I) 293T cells were transfected with control or GCN5-expressing vectors and 48 hr later processed for immunoblotting.
(J–L) GCN5 induces acetylation of a-tubulin. (J) CEwere incubated with 200 ng ofMyc, 100 ng or 300 ng of GCN5 (upper panel), or 100 ng or 500 ng of p300 (lower
panel). (K) Assembled microtubules were incubated with 100 ng or 500 ng of recombinant full-length GCN5 (upper panel) or p300 (lower panel) in the presence or
absence of 200 ng of purified c-Myc. (L) Purified assembled microtubules were incubated with recombinant c-Myc and GCN5-catalytic domain. The asterisk
indicates a nonspecific bacterial band copurified with GCN5-catalytic domain.
See also Figure S6.cytoplasmic extracts (Figure 6J, upper panel) resulted in
increased levels of acetylated a-tubulin. The addition of Myc
further increased the levels of a-tubulin acetylation induced by
GCN5 in cytoplasmic extracts (Figure 6J). Full-length recombi-nant GCN5 also induced the acetylation of a-tubulin present
in assembled microtubules (Figure 6K) and synergized with
c-Myc to promote further acetylation (Figure 6K, compare
lanes 1 to 4 and 2 to 5). The GCN5 catalytic domain alone wasCell 142, 480–493, August 6, 2010 ª2010 Elsevier Inc. 487
Tubulin
S M D D Density
GM DM
Tropomyosin
Myc
Myc-nick
Myc
Myc-nick
α
T5
8P
α
N
26
2
C2C12
D
GM DM
acetyl α-tub /DAPI
60μM20μM
c-Myc/DAPIc-Myc
60μM
20μM
Vector Myc-nick
Myc-nick*
Vector
60μM
acetyl α-tub /DAPI
C2C12 DM
E
Myc
Myc-nick
pr
im
ar
y
m
ou
se
m
yo
bl
as
ts
S D D Density
GM DM
α-tubulin
Tropomyosin
Troponin C
acetyl α-tub
Myc
nick*
nick* ΔMBII
ve
cto
r
ΔM
BI
I
R
D
R
ha
bd
om
yo
sa
rc
om
a
nic
k*
S D S D S D S D
HFF RHJT RD RH1
alveolar embryonal
1 2 3 8 16 weeks
mouse hindlimb muscles
Myc
Myc-nick
Tropomyosin
A
myc -/-
MyoD
TroponinC
Myogenin
α-tubulin
GM GM DM - S GM DM - S GM
myc +/+
MyoDC C
O
Troponin C
Desmin
acetyl α-tub
α-tubulin
Myc-nick*
nic
k*
ve
cto
r
hu
m
an
m
yo
bl
as
ts
(p
ec
to
ra
l)
H
Myogenin
TroponinC
GM GM DM GM DM
MyoD MyoD+nicknick
R
at
1
m
yc
-/-
α-tubulin
TroponinC
Tubulin
B
G
T
r
o
p
o
n
i
n
C
/
D
A
P
I
P
h
a
s
e
Rhabdomyosarcoma
MyoD MyoD+Myc-nick*
Rat1 myc+/+
N
1.0
0.2
0.4
0.6
0.8
1.2
1.4
1.6
C
C
al
pa
in
ac
tiv
ity
1.8
GM DM
primary myoblasts
Calpain3
acetyl α-tub
α-tubulin
Myc-nick*
hu
m
an
m
yo
bl
as
t
(re
ct
us
ab
do
m
in
us
)
hu
m
an
m
yo
bl
as
t
(r
ec
tu
s
ab
do
m
in
us
)
nic
k*
ve
cto
r
ML
F
Subtype
I
Troponin C
Myogenin
J
K
P
Myogenin
GM DM
TroponinC
Caveolin 3
Desmin
MyoD
α-tubulin
- + - + Myc-nick*
acetyl α-tub
Tropomyosin
C
2C
12
C
2C
12
Figure 7. Myc-Nick Accelerates Muscle Cell Differentiation
(A) Hindlimb muscles dissected from 1-, 2-, 3-, 8-, and 16-week-old mice were processed for immunoblotting using N-terminal anti-Myc sera (anti 143+274).
(B) Mouse primarymyoblasts isolated from hindlimbmuscles of 8-week-oldmicewere cultured as sparse cultures for 24 hr or as dense cultures in the presence of
either growth medium (GM) or differentiation medium (DM) for 3 days. Total cell extracts were immunoblotted for c-Myc (anti 143+274) and indicated proteins.
(C) Mouse primary myoblasts were cultured in GM or DM for 3 days, lysed in buffer A, and total calpain activity was measured using Suc-LLVY-AMC synthetic
substrate (n = 2; calpain activity in DM was compared with calpain activity in GM; set to 1 ± standard error of the mean [SEM]).
(D) C2C12 mouse myoblasts cultured at sparse (S), medium (M), or high densities (D). Dense cultures were harvested or switched to DM for 7 days. Total cell
extracts were immunoblotted for c-Myc using antibodies against total c-Myc (N262) or against phosphorylated T58 Myc, a signal for Myc degradation.
(E) C2C12 cells cultured in DM for 7 days and stained for endogenous c-Myc (anti-N262).
(F) C2C12 cells grown in the presence of GM or DM for 5 days and stained with anti-acetylated a-tubulin.
(G) Western blotting for Myc in rhabdomyosarcoma cell lines grown as dense or sparse cultures for 3 days.
(H and I) Human myoblasts expressing vector, or Myc-nick were cultured in DM and processed for immunoblotting after 4 days.
(J) Human myoblasts expressing vector or Myc-nick were cultured in DM and photographed after 2 days.
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sufficient to induce a-tubulin acetylation, but no synergy with
Myc was detected, most likely because association between
these two proteins occurs outside of GCN50s active site (Fig-
ure 6L). As a further control, we tested p300, a HAT that binds
the C terminus of Myc (Faiola et al., 2005). p300 neither induced
tubulin acetylation nor did it synergize with Myc (Figures 6J and
6K, bottom panels). These data indicate that GCN5 can specifi-
cally acetylate tubulin and that Myc augments tubulin acetylation
by binding to tubulin and recruiting GCN5.
Myc-Nick Is Produced in Differentiating Cells
and Tissues
When examining the expression of Myc-nick in adult mouse
tissues, we found that brain, cerebellum, and skeletal muscle
express significantly higher levels of Myc-nick than any other
tissue (Figure 7A, Figure S7A). Interestingly, both neuronal and
muscle differentiation requiremajor cytoskeletal rearrangements
that have been associated with increased microtubule stability
and elevated levels of acetylated a-tubulin. For example, it has
been demonstrated that the acetylation of a-tubulin by the
Elp3 acetyltransferase is required for proper cortical neuronal
migration and differentiation (Creppe et al., 2009). Increased
levels of acetylated a-tubulin are found during myogenic differ-
entiation (Gundersen et al., 1989). Importantly, inhibiting the
activity of the deacetylases HDAC6 and Sirt2 (known to deace-
tylate a-tubulin) generates augmented levels of acetylated
a-tubulin and promotes differentiation of myoblasts (Iezzi et al.,
2004). Furthermore, the presence of the primary cilium, a micro-
tubule-based antenna-like structure composed of acetylated
a-tubulin, is essential for cardiomyocyte differentiation (Clement
et al., 2009).
The extensive cytoskeletal changes that occur during muscle
differentiation are regulated by calcium and calpains (Dedieu
et al., 2004). The inhibition of calpain activity either by pharmaco-
logical inhibitors or by overexpression of Calpastatin (an endog-
enous inhibitor of calpains) blocks muscle cell differentiation
(Dedieu et al., 2004). In addition, both types of ubiquitous
calpains (m and m) were shown to regulate muscle cell differen-
tiation in vitro (Moyen et al., 2004). Moreover, mutations in the
calpain 3 gene (the muscle-specific calpain) cause limb girdle
muscle dystrophy 2A (LGMD2A) (Richard et al., 1995). Finally,
knocking out calpain r (the regulatory subunit shared by all
calcium-dependent calpains) is lethal due to impaired cardiovas-
cular development (Arthur et al., 2000).
To study the cleavage of Myc to Myc-nick during the process
of muscle differentiation, we employed human primary myo-
blasts purified from pectoral girdle, mouse myoblasts purified
from hindlimb muscles, and C2C12 cultured mouse myoblasts.(K) RD rhabdomyosarcoma cells expressing vector, Myc-nick, or Myc-nick DMB
(L) C2C12 cells expressing vector or Myc-nick were grown as dense cultures an
(M) C2C12 cells expressing vector or Myc-nick were grown to confluency and ha
lysates were immunoblotted with antibodies against the indicated proteins.
(N) Rat1 (myc+/+) cells expressingMyoD or MyoD +Myc-nick were cultured in DM
(upper panels).
(O) Rat1 (myc+/+) or Rat1 myc null (myc/) cells expressing vector (lane C) or My
processed for immunobloting.
(P) Rat myc null (myc/) cells expressing Myc-nick, MyoD, or MyoD + Myc-nick
See also Figure S7.When stimulated to differentiate, these cells displayed low
levels of full-length c-Myc and high levels of Myc-nick when
compared to undifferentiated cycling cells (Figures 7B and 7D;
Figure S7B). Interestingly, Myc-nick levels were higher in a rhab-
domyosarcoma cell line from the alveolar subtype (Figure 7G),
a very aggressive tumor derived from partially differentiated
muscle cells.
The increased levels of Myc-nick in differentiated primary
mouse myoblasts correlate with an increase in calpain 3 levels
(Figure 7B; Figure S7B) and in total calpain activity (Figure 7C).
Similarly, when C2C12 cells were stimulated to differentiate,
they also displayed an increase in total calpain activity (Fig-
ure S7C) and in the ability to cleave Myc in vitro (Figure S7D).
Importantly, the levels of acetylated a-tubulin were also elevated
during the process of differentiation (Figure 7B; Figures S7B and
S7F). Acetylation of a-tubulin is accompanied bymyoblast fusion
to form multinucleated myotubes (Figure 7F; Figure S7F). When
myoblasts are stimulated to differentiate they fuse into multinu-
cleated myotubes. In addition to displaying increased levels of
acetylated a-tubulin, these myotubes show decreased immu-
nostaining for nuclear Myc and increased cytoplasmic Myc
staining (Figure 7E). Conversely, undifferentiated satellite cells
in the same culture display nuclear staining for Myc (Figure S7E).
This is consistent with our results showing conversion of full-
length Myc into predominantly cytoplasmic Myc-nick.
In C2C12 cells, concomitant with increased Myc-nick abun-
dance, we observed a decrease in Myc-nick phosphorylation
at threonine 58 (T58) after the switch to differentiation conditions
(Figure 7D). Phospho-T58 mediates Fbw7-dependent degrada-
tion of Myc by the proteasome. Decreased phosphorylation at
this site is consistent with the notion that stabilization of Myc-
nick contributes to its elevated levels. Interestingly we found
that Myc-nick phosphorylation at T58 is also reduced in adult
muscle, brain, and cerebellum (Figure S7A and data not shown).
In summary, we found that during muscle differentiation there
is an increase in Myc-nick, concomitant with an elevation in cal-
pain activity and tubulin acetylation (Figures 7B–7D; Figure 7F;
Figures S7B–7D; Figure S7F).
Myc-Nick Accelerates Muscle Differentiation
We examined the effects of ectopic expression of Myc-nick* in
human primary myoblasts isolated from the pectoral girdle
(Figure 7H) and rectus abdominus (Figures 7I–7J), from the
human rhabdomyosarcoma cell line RD (Figure 7K), and in
C2C12 cells (Figures 7L and 7M). In all cells we found that
Myc-nick* expression accelerated muscle cell differentiation,
augmented a-tubulin acetylation, and elevated expression of
muscle-specific proteins (Figures 7H–7M).II (D106–143) were grown in DM for 4 days and processed for immunobloting.
d stimulated to differentiate for 4 days and then photographed.
rvested or stimulated to differentiate for 3 days and then harvested. Total cell
for 3 days and photographed (lower panels) or stained for Troponin C and DAPI
oD were cultured in GM, DM, or serum-free medium (lane S) for 4 days and
were grown in GM or DM for 3 days and processed for immunoblotting.
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The expression of Myc-nick* in C2C12 myoblasts promoted
an increase in cell fusion not only in confluent cultures (Fig-
ure 7L; Figure S7H) but also in sparse cultures (Figure S7G).
The role of Myc-nick in promoting muscle cell differentiation is
partially dependent on MBII, as the differentiation of RD and
C2C12 cells by Myc-nick can be delayed but not inhibited by
the deletion of MBII (Figure 7K; Figure S7I).
To examine the requirement for Myc-nick production during
differentiation further, we first tested calpain inhibitor XII and
found that it reduces differentiation and tubulin acetylation
(Figure S7J). Next we employed c-Myc mutant (D291–300),
which is deficient in cleavage to Myc-nick. Similar to full-length
WT c-Myc, this mutant can induce proliferation, apoptosis,
fibrillarin expression, and phosphorylated H2AX in Rat1 myc
null cells (Figures S7L–S7M). However the D291–300 c-Myc
mutant significantly reduces C2C12 cell differentiation when
compared to c-Myc, even though the proteins are expressed
at equal levels. Whereas full-length c-Myc only blocks the
fusion of C2C12 myoblasts, the c-Myc mutant (D291–300) with
reduced ability to generate Myc-nick dramatically reduces the
expression of muscle markers in addition to blocking fusion
(Figures S7N–S7O).
Myc-Nick Renders Rat1myc Null Cells Competent
to Differentiate
MyoD has been long known to induce transdifferentiation in
diverse cell types. We found that MyoD induces expression of
muscle-specific markers in Rat1 fibroblasts but not in Rat1
myc null fibroblasts (Figure 7O), indicating thatmyc is necessary
for the transdifferentiation process. Expressing Myc-nick
together with MyoD in myc+/+ Rat1 fibroblasts further elevated
the levels of muscle-specific markers and promoted cell fusion
compared to MyoD alone (Figure 7N). Importantly, we find that
in Rat1myc null cells, the coexpression of Myc-nick (Figure S7K)
permitted transdifferentiation to muscle in response to MyoD
(Figure 7P). This experiment indicates that Myc-nick is sufficient
for MyoD-induced transdifferentiation, supporting the idea that
conversion of full-length Myc to Myc-nick is important in
MyoD-induced differentiation.
DISCUSSION
Recent studies have demonstrated that Myc directly regulates
transcriptional activation through the three RNA polymerases,
as well as transcriptional repression, and DNA replication (Eilers
and Eisenman, 2008). Here we identified and characterizedMyc-
nick, a novel form of Myc performing transcription-independent
functions in the cytoplasm. One of these functions is to regulate
a-tubulin acetylation in cooperation with the HAT GCN5. More-
over, Myc-nick levels are elevated in differentiated muscle
tissues and Myc-nick overexpression accelerates muscle cell
differentiation.
Despite its widespread expression, Myc-nick has not been
previously characterized. There are several likely reasons for this.
First, the most commonly used antibodies against Myc (such as
9E10) recognize its C terminus and would not detect Myc-nick.
Second, the proportion of Myc-nick to Myc increases when
cells are grown as confluent cultures, conditions that are not490 Cell 142, 480–493, August 6, 2010 ª2010 Elsevier Inc.commonly employed when studying Myc proteins. Third, most
studies use total protein or nuclear extracts and have not analyzed
the cytoplasmic pool of Myc. Fourth, Myc-nick may have been
mistaken for the similarly sized MycS protein (Hann et al., 1988),
a nuclear localized product of internal translation initiation.
Calpain Cleavage as a Posttranslational Functional
Switch
We found that Myc-nick is generated in the cytoplasm by
calpain-mediated cleavage of full-length Myc. Cytoplasmic
cleavage by calpains has been reported for over 100 proteins
including many cytoskeletal proteins, membrane receptors,
and transcription factors (Tompa et al., 2004). This number is
probably an underestimate because the lack of a clearly defined
consensus cleavage site for calpains makes the identification of
novel calpain substrates difficult. For most substrates the role of
calpain cleavage is not known. However, there are several note-
worthy examples of calpain cleavage operating as a functional
switch (Abe and Takeichi, 2007; Yousefi et al., 2006). Here we
have shown that the cleavage of Myc by calpain converts this
predominantly nuclear transcription factor into Myc-nick, a cyto-
solic factor that regulates a-tubulin acetylation. Based on our
findings and the examples in the literature, we surmise that the
partial proteolytic cleavage of proteins by calpains functions as
an irreversible posttranslational modification.
A Role for Myc-Nick in a-Tubulin Acetylation
We have shown that Myc-nick mediates the acetylation of
a-tubulin by forming a complex with microtubules and the HAT
GCN5. GCN5 has been long known to associate with nuclear
Myc through the highly conserved Myc box II, a region retained
in Myc-nick. Although tubulin acetylation was first described
20 years ago, little is known about the enzymes that catalyze
this reaction. Recently Elp3, a histone acetyltransferase, was
demonstrated to be critical in acetylation of a-tubulin in cortical
projection neurons, an event linked to neural differentiation and
migration (Creppe et al., 2009). We surmise that GCN5 repre-
sents another acetyltransferase targeting tubulin. Deacetylation
of a-tubulin is mediated by both HDAC6 and Sirt2 (Hubbert
et al., 2002; Matsuyama et al., 2002; North et al., 2003). However
the increase in acetylated a-tubulin by Myc-nick does not occur
through modulation of HDAC activity (Figures S6E and S6F).
A connection between a-tubulin acetylation and calpain acti-
vation was previously suggested by two independent studies.
First, calcium depletion, which inactivates calpains, was shown
to decrease the levels of acetylated a-tubulin in epithelial cells
(Ivanov et al., 2006). Second, the ectopic expression of calpain
6 causes microtubule stabilization, elevates the levels of acety-
lated a-tubulin, and impairs cytokinesis in HeLa cells (Tonami
et al., 2007). Our findings suggest that the induction of a-tubulin
acetylation by calpains could be mediated at least in part by
Myc-nick and GCN5.
The Role of Myc-Nick in Terminal Differentiation
The role of Myc family members in differentiation is complex.
Endogenous Myc is strongly downregulated during terminal
differentiation of many cell types. Moreover, ectopic expression
of Myc has been shown to block terminal differentiation. The
ability of Myc to negatively regulate differentiation is consistent
with its role in maintaining pluripotency in ES cells and in the
generation of induced pluripotent stem (iPS) cells (Cartwright
et al., 2005; Takahashi et al., 2007). However, Myc has also
been implicated in promoting both proliferation and differentia-
tion in specific cellular contexts such as in progenitor cells of
the skin (Gandarillas and Watt, 1997; Gebhardt et al., 2006), B
lymphocytes (Habib et al., 2007), and hematopoietic stem cells
(Wilson et al., 2004). Our data suggest that whereas full-length
Myc blocks differentiation at the transcriptional level, Myc-nick
may be involved in promoting differentiation through transcrip-
tion-independent mechanisms. In agreement with this hypoth-
esis there have been numerous reports of Myc antigenicity
localized predominantly in the cytoplasm of differentiated cells
(see Introduction). In addition, we show that ectopic expression
of Myc-nick accelerates muscle cell differentiation and renders
Rat1 myc null cells competent to differentiate into muscle
following introduction of MyoD.
A number of studies have shown a strong correlation between
muscle cell differentiation, calcium influx, and calpain activation
(Dedieu et al., 2004; Kumar et al., 1992). In addition, limb girdle
muscular dystrophy 2A (LGMD2A) is caused by mutations in
calpain 3 that affect its activity (Richard et al., 1995). During
the process of normal differentiation, myoblasts elongate and
fuse into syncytial myotubes. An early event during this process
is the remodeling of the microtubule cytoskeleton, involving
disassembly of the centrosome and the alignment of stable
microtubules into a parallel array along the long axis of the cell.
We observed an increase in the levels of acetylated a-tubulin
(an indicator ofmicrotubule stabilization and cytoskeletal reorga-
nization) and an elevation in Myc-nick abundance during muscle
cell differentiation. Induction of a-tubulin acetylation and micro-
tubule stabilization are likely to be important events in terminal
differentiation especially when cells must establish and maintain
a new shape. Acetylation of a-tubulin was also demonstrated to
regulate cortical neuron differentiation and migration (Creppe
et al., 2009).
We propose a model for the regulation of Myc by calpains and
for the function of Myc-nick. During proliferation, full-length Myc
is rapidly synthesized and transported to the nucleus where it
transcriptionally activates growth- and proliferation-related
genes and represses genes involved in differentiation. External
cues that stimulate differentiation, such as cell-cell contact,
and calcium influx can lead to the activation of calpains. Acti-
vated calpains interact with andmay retain Myc in the cytoplasm
where it is cleaved to produce Myc-nick. As the cleavage
removes the nuclear localization sequence (NLS) and the DNA-
and Max-binding domains, Myc-nick is predominantly cyto-
plasmic and transcriptionally inactive. Indeed we have shown
that Myc-nick, when expressed in cells devoid of full-length
Myc, does not stimulate proliferation, growth, or apoptosis—
the transcription-dependent functions of full-length Myc. In
suchMyc-nick-expressing cells we instead observe morpholog-
ical changes and increased tubulin acetylation, which are unique
to Myc-nick. During muscle differentiation Myc-nick appears to
be stabilized by dephosphorylation of threonine 58 within the
Myc box I phosphodegron. We propose that one of the functions
carried out byMyc-nick in the cytoplasm involves binding tubulinand recruiting GCN5 to mediate a-tubulin acetylation. Myc-nick
is also likely to have additional functions and partners in the cyto-
plasm as the deletion of MBII in Myc-nick, which should block
the interaction with GCN5, only partially reduced the ability of
Myc-nick to promote muscle differentiation. We predict that
the functions carried out by Myc-nick in the cytoplasm coop-
erate to promote cytoskeletal changes that can further drive
terminal differentiation. In our model, the cleavage of Myc by
calpains has two roles. First, it helps diminish nuclear Myc abun-
dance preventing newly synthesized Myc from entering the
nucleus, therefore eliminating the transcriptional blockade to
differentiation caused by Myc. Second, the production of Myc-
nick influences cytoskeletal organization and facilitates terminal
differentiation. We predict that Myc-nick will play a general role
linkingmyc to both nuclear functions and cytoplasmic organiza-
tion during differentiation of a wide variety of cell types.
EXPERIMENTAL PROCEDURES
Retroviral Infection and Transfection
For retroviral production, 293T cells were cotransfected with pBabe-puro
vector expressing Myc clones and amphotropic helper. Infected cells were
selected with 2 mg/ml puromycin for 4 days. Rat1myc null cells were harvested
10–14 days after infection and C2C12 cells were stimulated to differentiate
after selection. For overexpression experiments, 293T (transfected with
Fugene-Roche) cells were harvested 3 days after transfection with a change
in culture medium 24 hr before harvesting. Sparse cultures (S) are about
20% confluent, medium cultures (M) are about 40%–60% confluent, and
dense cultures (D) are grown as confluent cultures for 2–4 days.
Total Cell Lysates and Nuclear and Cytoplasmic Fractionation
For total extracts, cells were lysed in either boiling sample buffer or in RIPA
buffer. For cellular fractionation, cells were lysed in buffer A on ice for 20 min,
centrifuged for 3 min, and the supernatant employed as the cytoplasmic frac-
tion. The pellet was resuspended in buffer B, rotated for 20min, sonicated, and
centrifuged for 10 min. The supernatant was employed as the nuclear fraction.
Ten to twentymicrogramsof total extracts or 10mgof nuclear and30mgof cyto-
plasmic extracts were probed overnight with indicated antibodies. See
Extended Experimental Procedures for composition of buffers.
Immunofluorescence
Cells were grown on glass coverslips and fixed with 4% paraformaldehyde
for 20 min, permeabilized with 0.5% Triton X-100 for 5 min, and blocked
with Image IT FX signal enhancer (Invitrogen) for 30 min. Primary and
secondary antibodies were diluted in PBS at 1:200 and incubated for 1 hr.
In Vitro Cleavage of Myc
All cDNAs were cloned into pCS2+ and were transcribed from the SP6
promoter using the Promega wheat germ system, in the presence of cold
(Promega) or 35[S]-labeled methionine (Perkin Elmer) according to the manu-
facturer’s instructions. For the in vitro cleavage experiments, Myc (1 ml IVT
Myc or 1 mg recombinant Myc) was incubated with 30 mg of nuclear or cyto-
plasmic extracts in 20 ml of buffer G at 37C and the samples were processed
for autoradiography or western blot as specified. Nuclear and cytoplasmic
fractions were dissolved in the same buffer and adjusted to identical salt
concentration for these experiments. For Myc cleavage using recombinant
calpains, 1 ml IVT c-Myc or 0.25 mg of purified c-Myc was incubated with the
indicated amounts of calpains in the presence of 20 ml buffer G. Total calpain
activity was measured using a Calbiochem kit.
In Vitro Tubulin Acetylation Assays
CE (30 mg) or purified assembled microtubules (1 mg) were incubated with 1 ml
of IVT c-Myc or IVT vector or with recombinant Myc for 1 hr in the presence ofCell 142, 480–493, August 6, 2010 ª2010 Elsevier Inc. 491
acetylation buffer. Assembled microtubules were incubated at 30C and CE
at 37C.
See Extended Experimental Procedures for buffer composition, constructs,
siRNA sequence, pharmacological inhibitors, antibodies, cell lines, and culture
media.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at doi:10.1016/j.cell.
2010.06.037.
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